Autocallable Multi Barrier Reverse Convertible

Symbol: KOFUDU
Underlyings: Merck & Co. / Pfizer
ISIN: CH1266485304
Issuer:
UBS

Chart

    
Bid 59.75
    
Ask 0.00
Created with Highcharts 8.0.009:3010:0010:3011:0011:3012:0012:3013:0013:3014:0014:3015:0015:3016:0016:3017:00020406080

SIX Structured Products trading

SIX Structured Products Bid Ask Notation
Please note that data is only available after start of trading.

Performance

Closing prev. day 58.65
Diff. absolute / % 1.00 +1.71%

Determined prices

Last Price 57.45 Volume 5,000
Time 09:55:20 Date 09/04/2025

More Product Information

Core Data

Name Autocallable Multi Barrier Reverse Convertible
ISIN CH1266485304
Valor 126648530
Symbol KOFUDU
Quotation in percent Yes
Coupon p.a. 8.50%
Coupon Premium 4.11%
Coupon Yield 4.39%
Type Multi Barrier Reverse Convertibles
SVSP Code 1230
Barrier reached Yes (Pfizer Inc. - 07/04/2025)
COSI Product No
Exercise type American
Currency US Dollar
First Trading Date 24/05/2023
Date of maturity 27/05/2025
Last trading day 19/05/2025
Settlement Type Path-dependent
IRS 871m Potentially in scope for combined transactions
Currency safeguarded No
Pricing Clean
Issuer UBS

Key data

Sideways yield p.a. -

market maker quality Date: 14/04/2025

Average Spread 1.70%
Last Best Bid Price 58.70 %
Last Best Ask Price 59.65 %
Last Best Bid Volume 100,000
Last Best Ask Volume 100,000
Average Buy Volume 27,355
Average Sell Volume 27,355
Average Buy Value 15,974 USD
Average Sell Value 16,248 USD
Spreads Availability Ratio 96.02%
Quote Availability 96.25%

Underlyings

Name Pfizer Inc. Merck & Co. Inc.
ISIN US7170811035 US58933Y1055
Price 19.805 EUR 68.90 EUR
Date 16/04/25 07:24 16/04/25 07:22
Cap 36.75 USD 114.76 USD
Distance to Cap -13.87 -35
Distance to Cap in % -60.62% -43.88%
Is Cap Level reached No No
Barrier 22.05 USD 68.856 USD
Distance to Barrier 0.94 10.904
Distance to Barrier in % 4.09% 13.67%
Is Barrier reached Yes No

Cookie notification


Please wait...
The data push was deactivated due to a timeout. Please click "Refresh page" to continue.